Clinical Trial: Real-World Outcomes of First-Line Nivolumab + Ipilimumab With Chemotherapy in Non-Small Cell Lung Cancer in Poland

U.S., April 15 -- ClinicalTrials.gov registry received information related to the study (NCT07526961) titled 'Real-World Outcomes of First-Line Nivolumab + Ipilimumab With Chemotherapy in Non-Small Cell Lung Cancer in Poland' on April 08.

Brief Summary: This study will review medical records from hospitals in Poland to describe the demographics and baseline clinical characteristics of adults with advanced non-small cell lung cancer who received first-line nivolumab plus ipilimumab with chemotherapy in routine care between 01 January 2023 and 31 December 2023. The study will also describe treatment patterns and clinical outcomes, associated with immunotherapy.

Study Start Date: Dec. 01, 2025

Study Type: OBSERVATIONAL

Condition: Non-Smal...